Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 4/2020

01-08-2020 | Computed Tomography | Case Report

68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report

Authors: Aysar Khalaf, Nader Hirmas, Farah Anwer, Akram Al-Ibraheem

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2020

Login to get access

Abstract

Non-ossifying fibroma (NOF) is a common benign bone tumor with a high probability of occurrence in children and adolescents. It is commonly seen in the metaphysis of long bones, eccentrically located, and can coexist with other malignant tumors such as neuroendocrine tumors (NET). To date, plain radiographs play a major role in the diagnosis of these benign bone tumors. Herein, we report the case of a 13-year-old male patient who was diagnosed with pulmonary NET and underwent right lung lobectomy for a hilar mass which later revealed a well-differentiated NET. The follow-up 68Ga DOTA-TOC PET/CT showed a focal somatostatin receptor expression in the left distal femur, with corresponding CT component findings of a well-defined osteolytic bone lesion located within the medial aspect of the left distal femoral metaphysis, strongly indicative of NOF. To the best of our knowledge, this is the first reported case of such an occurrence.
Literature
1.
go back to reference Hetts SW, Hinchey SD, Wilson R, Franc B. Case 110: nonossifying fibroma. Radiology. 2007;243:288–92.CrossRef Hetts SW, Hinchey SD, Wilson R, Franc B. Case 110: nonossifying fibroma. Radiology. 2007;243:288–92.CrossRef
2.
go back to reference Hod N, Levi Y, Fire G, Ayash D, Somekh M, Horne T. Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains. Nucl Med Commun. 2007;28:25–33.CrossRef Hod N, Levi Y, Fire G, Ayash D, Somekh M, Horne T. Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains. Nucl Med Commun. 2007;28:25–33.CrossRef
3.
go back to reference Goldin A, Muzykewicz DA, Dwek J, Mubarak SJ. The aetiology of the non-ossifying fibroma of the distal femur and its relationship to the surrounding soft tissues. J Child Orthop. 2017;11:373–9.CrossRef Goldin A, Muzykewicz DA, Dwek J, Mubarak SJ. The aetiology of the non-ossifying fibroma of the distal femur and its relationship to the surrounding soft tissues. J Child Orthop. 2017;11:373–9.CrossRef
4.
go back to reference Herget GW, Mauer D, Kraus T, El Tayeh A, Uhl M, Norbert PS, et al. Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow up. BMC Musculoskelet Disord. 2016;17:147.CrossRef Herget GW, Mauer D, Kraus T, El Tayeh A, Uhl M, Norbert PS, et al. Non-ossifying fibroma: natural history with an emphasis on a stage-related growth, fracture risk and the need for follow up. BMC Musculoskelet Disord. 2016;17:147.CrossRef
5.
go back to reference Hirmas N, Jadaan R, Al-Ibraheem A. Peptide receptor radionuclide therapy and the treatment of gastroentero-pancreatic neuroendocrine tumors: current findings and future perspectives. Nucl Med Mol Imaging. 2018;52:190–9.CrossRef Hirmas N, Jadaan R, Al-Ibraheem A. Peptide receptor radionuclide therapy and the treatment of gastroentero-pancreatic neuroendocrine tumors: current findings and future perspectives. Nucl Med Mol Imaging. 2018;52:190–9.CrossRef
6.
go back to reference Prasad V, Ambrosini V, Alavi A, Fanti S, Baum RP. PET/CT in neuroendocrine tumors: evaluation of receptor status and metabolism. PET Clin. 2008:3355–79. Prasad V, Ambrosini V, Alavi A, Fanti S, Baum RP. PET/CT in neuroendocrine tumors: evaluation of receptor status and metabolism. PET Clin. 2008:3355–79.
7.
go back to reference Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2008;36:228–47.CrossRef Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2008;36:228–47.CrossRef
9.
go back to reference Błaż M, Palczewski P, Swiątkowski J, Gołębiowski M. Cortical fibrous defects and non-ossifying fibromas in children and young adults: the analysis of radiological features in 28 cases and a review of literature. Pol J Radiol. 2011;76:32–9.PubMedPubMedCentral Błaż M, Palczewski P, Swiątkowski J, Gołębiowski M. Cortical fibrous defects and non-ossifying fibromas in children and young adults: the analysis of radiological features in 28 cases and a review of literature. Pol J Radiol. 2011;76:32–9.PubMedPubMedCentral
10.
go back to reference Jee WH, Choe BY, Kang HS, Suh KJ, Suh JS, Ryu KN, et al. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–2.CrossRef Jee WH, Choe BY, Kang HS, Suh KJ, Suh JS, Ryu KN, et al. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–2.CrossRef
11.
go back to reference Stacy GS, Dixon LB. Pitfalls in MR image interpretation prompting referrals to an orthopedic oncology clinic. Radiographics. 2007;27:805–26.CrossRef Stacy GS, Dixon LB. Pitfalls in MR image interpretation prompting referrals to an orthopedic oncology clinic. Radiographics. 2007;27:805–26.CrossRef
12.
go back to reference Al Ibraheem A, Bundschuh RA, Notni J, Buck A, Winter A, Wester HJ, et al. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2011;38:2005–13.CrossRef Al Ibraheem A, Bundschuh RA, Notni J, Buck A, Winter A, Wester HJ, et al. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2011;38:2005–13.CrossRef
13.
go back to reference Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, Normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500–16.CrossRef Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, Normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500–16.CrossRef
14.
go back to reference Reubi JC, Waser B, Schaer JC, Laissue AJ. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissue using receptor autoradiography with subtype selective ligands. Eur J Nucl Med. 2001;28:836–46.CrossRef Reubi JC, Waser B, Schaer JC, Laissue AJ. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissue using receptor autoradiography with subtype selective ligands. Eur J Nucl Med. 2001;28:836–46.CrossRef
15.
go back to reference Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. Ga68 DOTATOC PET/CT and somatostatin receptor expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging. 2011;38:1224–36.CrossRef Boy C, Heusner TA, Poeppel TD, Redmann-Bischofs A, Unger N, Jentzen W, et al. Ga68 DOTATOC PET/CT and somatostatin receptor expression in normal human tissue: correlation of sst2 mRNA and SUVmax. Eur J Nucl Med Mol Imaging. 2011;38:1224–36.CrossRef
Metadata
Title
68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report
Authors
Aysar Khalaf
Nader Hirmas
Farah Anwer
Akram Al-Ibraheem
Publication date
01-08-2020
Publisher
Springer Singapore
Published in
Nuclear Medicine and Molecular Imaging / Issue 4/2020
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-020-00650-x

Other articles of this Issue 4/2020

Nuclear Medicine and Molecular Imaging 4/2020 Go to the issue